| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.0M | +55.8% |
| SG&A Expense | $24.4M | +120.5% |
| Operating Income | -$71.4M | -73.2% |
| Interest Expense | $302K | -16.3% |
| Pre-tax Income | -$70.2M | -3.5% |
| Income Tax | $1.3M | +1772.1% |
| Net Income | -$71.5M | -5.3% |
| EPS (Basic) | -$2.48 | +85.7% |
| EPS (Diluted) | -$2.48 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.6M | -32.6% |
| Current Assets | $148.2M | -33.2% |
| Total Assets | $151.8M | -31.7% |
| Current Liabilities | $10.7M | +3.6% |
| Total Liabilities | $13.0M | +25.0% |
| Stockholders' Equity | $138.9M | -34.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.7M | -46.9% |
| Capital Expenditures | $690K | +351.0% |
| Investing Cash Flow | -$690K | -351.0% |
| Financing Cash Flow | $253.0M | +0.0% |
| Free Cash Flow | -$60.4M | -48.1% |
| +85.7% |